Figma shares rise as Bank of America resumes coverage with a ‘Buy’ rating
Imugene raises $11.1 million to advance azer-cel after complete responses in early cohort
Shell flags 'significantly higher' gas trading and sells South Africa business - UPDATE
Imugene reports second BTKi cohort response - ICYMI
Imugene CEO details azer-cel trial milestone - ICYMI
Anthropic clears export hurdle for Fable 5, easing a threat to its IPO story
Imugene reports second complete response in azer-cel BTKi cohort
Fed may adopt leaner communications strategy under Warsh, says Deutsche Bank
Nasdaq leads Wall Street higher, Dow Jones notches new record as second quarter ends
Imugene reports first complete response in azer-cel BTKi cohort
FDA Fast Track opens new path for Imugene's Azer-cel - ICYMI
Inside Biotech: FDA fast-track nod sharpens focus on Imugene's off-the-shelf CAR T ambitions
Thor Energy lifted by hydrogen project update
Imugene showcases Azer-Cel progress at ASCO - ICYMI
Dow Jones, Nasdaq close at record levels as Trump says US-Iran peace talks are advancing
Costco's value strategy, membership growth support outlook after strong quarter, says Jefferies
Anthropic confidentially files to go public in the US
Iovance Biotherapeutics pushes cell therapy platform into solid tumor market
Small Cap Watch: commercial expansion updates drive news flow
Imugene presents azer-cel data at ASCO as trial expands into new cohort
Imugene targets blood cancer with off-the-shelf CAR-T - ICYMI
Costco reports strong sales growth in fiscal third quarter
Imugene doses first patient in BTKi combination cohort for azer-cel study
Imugene strengthens board with biotech and pharma appointments
IBM shares extend rally as Wedbush calls US quantum investment a "new catalyst"
Imugene valuation points to 129% upside as broker backs azer-cel strategy
Apple reports record March quarter revenue on strong iPhone sales
Imugene secures shareholder backing, completes $16 million capital raising package
Lindian raises A$100M to fast-track Kangankunde expansion and downstream push
Shares slide after Mkango Resources completes £12.5m fundraise, but oversubscription signals longer-term confidence
Imugene launches $20M capital raise to advance azer-cel clinical program
Premier African Minerals falls 8% as emergency fundraise highlights Zulu project strain
Imugene highlights azer-cel progress as trial patient enters remission
Imugene reports strong early response rates for azer-cel in lymphoma study
Rathbones upgraded to 'buy' as new CEO sets out plan to become the UK's best wealth manager
Imugene to showcase azer-cel data at major US healthcare conference
Imugene secures $2.7m R&D tax refund to support clinical programs
Nasdaq drops for third straight week as gold and silver tank
SoFi posts record quarterly revenue, adds over 1M members
Chevron delivers mixed earnings for fourth quarter
Dow likely to extend record while tech stocks flounder
Pinterest downgraded, price target lowered on emerging AI risks
Imugene secures FDA backing for Azer-cel registration pathway
Small Cap Watch: Results come through for several explorers
SentinelOne shares drop on weak Q4 guidance, CFO departure
Imugene hits 82% response rate in blood cancer trial - ICYMI
Dow futures steady as markets try to rebound from shaky start to the week
Imugene lifts response rate to 82% in Phase 1b trial of azer-cel CAR-T therapy
Imugene and JW Therapeutics launch collaborative program to bring CD19 CAR-T innovation to solid tumours